While the degree of breast cancer susceptibility is still unclear, some studies examining recurrent PALB2 mutations tested in patients unselected for family history have demonstrated a risk and penetrance as high as those arising from BRCA2 mutations [6,7]. This evidence concerns the gene BRCA2 and breast cancer.